BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,494,429 | +1.8% | 1,642,180 | +35.1% | 0.03% | +6.7% |
| Q2 2023 | $38,797,504 | +92.4% | 1,215,080 | +84.5% | 0.03% | +100.0% |
| Q1 2023 | $20,165,291 | -23.5% | 658,566 | -2.2% | 0.02% | -28.6% |
| Q4 2022 | $26,348,016 | +8.2% | 673,690 | +31.9% | 0.02% | +5.0% |
| Q3 2022 | $24,341,000 | +115.4% | 510,931 | +75.0% | 0.02% | +122.2% |
| Q2 2022 | $11,302,000 | -30.4% | 291,962 | +3.0% | 0.01% | -18.2% |
| Q1 2022 | $16,245,000 | -9.5% | 283,509 | +25.9% | 0.01% | 0.0% |
| Q4 2021 | $17,948,000 | -18.9% | 225,223 | -11.5% | 0.01% | -21.4% |
| Q3 2021 | $22,131,000 | -33.0% | 254,355 | -0.9% | 0.01% | -30.0% |
| Q2 2021 | $33,022,000 | +79.8% | 256,565 | +11.8% | 0.02% | +81.8% |
| Q1 2021 | $18,361,000 | +10.1% | 229,401 | +12.3% | 0.01% | 0.0% |
| Q4 2020 | $16,674,000 | – | 204,242 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |